UBS Maintains Sell on Nevro, Raises Price Target to $77

UBS maintains Nevro (NYSE:NVRO) with a Sell and raises the price target from $44 to $77.

Benzinga · 11/08/2019 12:43

UBS maintains Nevro (NYSE:NVRO) with a Sell and raises the price target from $44 to $77.